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RESEARCH ARTICLE
Neural crest cell-autonomous roles of fibronectin in cardiovascular
development
Xia Wang and Sophie Astrof*
ABSTRACT
The chemical and mechanical properties of extracellular matrices
(ECMs) modulate diverse aspects of cellular fates; however, how
regional heterogeneity in ECM composition regulates developmental
programs is not well understood. We discovered that fibronectin 1
(Fn1) is expressed in strikingly non-uniform patterns during mouse
development, suggesting that regionalized synthesis of the ECM
plays cell-specific regulatory roles during embryogenesis. To test this
hypothesis, we ablated Fn1 in the neural crest (NC), a population of
multi-potent progenitors expressing high levels of Fn1. We found that
Fn1 synthesized by the NC mediated morphogenesis of the aortic
arch artery and differentiation of NC cells into vascular smooth
muscle cells (VSMCs) by regulating Notch signaling. We show that
NC Fn1 signals in an NC cell-autonomous manner through integrin
α5β1 expressed by the NC, leading to activation of Notch and
differentiation of VSMCs. Our data demonstrate an essential role of
the localized synthesis of Fn1 in cardiovascular development and
spatial regulation of Notch signaling.
KEY WORDS: Cardiovascular development, Fibronectin, Integrin
α5β1, Neural crest, Notch, Lateral induction, Vascular smooth
muscle cells
INTRODUCTION
Aortic arch arteries (AAAs) route oxygenated blood from the heart
to the rest of the body. Malformations in this vascular tree are
common causes of morbidity and mortality in patients with
congenital heart disease (CHD) (Go et al., 2013; Moon, 2008,
2006). Development of the AAAs occurs similarly in humans and in
mice, and results from asymmetrical remodeling of the three pairs of
pharyngeal arch arteries (PAAs) that are initially positioned
symmetrically around the midline (Conway et al., 2003; Stoller
and Epstein, 2005) (Fig. 1A,B). Animal models indicate that
defective remodeling of initially well-formed, symmetrical PAAs
may cause some forms of CHD, e.g. the Alagille syndrome (High
and Epstein, 2008). In this syndrome, as well as in many non-
syndromic CHD patients, the AAA abnormalities stem, in part, from
defects in derivatives of the 4th pair of PAAs (the left and/or the
right). The left 4th PAA gives rise to the aortic arch and the right 4th
PAA gives rise to the proximal segment of the right subclavian
artery (Stoller and Epstein, 2005). Regression of the left 4th PAA
results in the interrupted aortic arch, which is lethal. Regression of
the right 4th PAA results in a vascular abnormality called
retroesophageal right subclavian artery (RERSA), in which the
right subclavian artery originates from the descending aorta on the
left, instead of the brachiocephalic trunk on the right (Stoller and
Epstein, 2005).
The development of vascular smooth muscle cells (VSMCs)
around the three symmetrical pairs of PAAs is necessary to prevent
premature regression of these vessels and to facilitate their
asymmetrical remodeling (High et al., 2007; Hutson and Kirby,
2007; Yashiro et al., 2007). VSMCs surrounding the PAA
endothelium derive from the neural crest (NC) – a population of
neuroectodermal stem cells that originate along the anterior–
posterior axis at the dorsal margin of the neural tube (Donoghue
et al., 2008; Le Douarin and Kalcheim, 1999). NC cells detach from
the neural tube and migrate extensive distances along the
stereotypical paths characteristic of their axial positions of origin.
Upon arrival at their destinations, NC-derived cells participate in the
morphogenesis of numerous organs and differentiate into a diverse
array of cell types, including neurons and glia of the peripheral
nervous system, bones and cartilage of the face, melanocytes of the
skin, and VSMCs of the cerebral and pharyngeal vasculature (Crane
and Trainor, 2006; Le Douarin and Kalcheim, 1999). NC cells that
migrate into the pharyngeal arches 3-6 and into the heart are called
cardiac NC cells. The cardiac NC originates from the region of the
dorsal neural tube located between the otic pit and the 4th somite
(Chan et al., 2004; Hutson and Kirby, 2007).
Studies in chickens and mice show that NC cell fates are
influenced by signals emanating from their host tissues (Chen et al.,
2012; Donoghue et al., 2008; Ferguson and Graham, 2004; Itasaki
et al., 1996; Trainor and Krumlauf, 2000; Trainor et al., 2002a,b). In
the pharyngeal arches, Notch signaling from the PAA endothelium
mediates differentiation of the adjacent NC cell layers into VSMCs,
and the region of active Notch around the PAA endothelium
corresponds to the area within which NC cells undergo VSMC
differentiation (High et al., 2008, 2007; Manderfield et al., 2012).
However, mechanisms that limit the activation of Notch to the few
NC cell layers proximal to PAA endothelium are unknown.
In our prior work, we made the unexpected observation that
fibronectin 1 (Fn1)mRNAand protein are highly enriched in distinct
regions of the mouse embryo, including regions corresponding to
the developingNC and the pharyngeal arches 3, 4 and 6 (Mittal et al.,
2010). Interestingly, many other ECM glycoproteins are also
non-uniformly distributed during embryogenesis (reviewed in
Astrof, 2013; Watt and Huck, 2013). This suggests that the highly
localized distribution of ECM components during embryo
development generates distinct microenvironments that can
influence morphogenetic events in a spatially dependent manner.
To test this hypothesis, we conditionally inactivated Fn1 in the NC,
and found that NC-synthesized Fn1 regulates AAA morphogenesis
and the differentiation of NC cells into VSMCs. Our studies
indicated that NC-synthesized Fn1 regulates VSMC differentiation
by facilitating Notch signal transduction from the endothelium to
the adjacent NC cells. Furthermore, we found that Notch activationReceived 13 April 2015; Accepted 3 November 2015
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in the NC cells surrounding the PAA endothelium is limited to the
NC cells expressing Fn1.
In order to further understand the mechanisms by which Fn1
regulates activation of Notch and the differentiation of NC cells into
VSMCs, we sought to identify receptors on NC cells that could
transduce Fn1 signaling. Integrins are a major class of ECM
receptors that connect the ECM with the actin cytoskeleton and
transduce ECM signals into cells (Assoian and Schwartz, 2001;
Giancotti and Tarone, 2003; Hynes, 2002; Schwartz and Assoian,
2001). Integrins are heterodimers comprising α- and β-subunits
encoded by different genes; 18 genes encoding α-chains and 8 genes
encoding β-chains give rise to 24 distinct integrin heterodimers with
distinct and overlapping specificities for ECM ligands (Hynes,
2012). Here, we show that enrichment of Fn1 around the PAA
endothelium facilitates Notch activation and imparts the spatial
specificity to Notch signaling by signaling through integrin α5β1.
Our studies highlight the indispensable role of localized sources of
Fn1 in cardiovascular development, and suggest that specific, spatio-
temporal expression patterns of ECM proteins are important for
regulating distinct morphogenetic programs.
RESULTS
Ablation of Fn1 in the NC results in cardiovascular
abnormalities and perinatal lethality
Fn1 mRNA becomes detectable in the cardiac NC at about the
8th-10th somite stage of mouse development, and its expression
is maintained in the dorsal neural tube at least until the 23rd somite
stage (Mittal et al., 2010). Studies using Fn1flox/flox mice, a
strain generated 14 years ago, show that the Fn1 protein is
downregulated within 24 h of Cre expression (Sakai et al., 2001).
However, 24 h is a significant fraction of the 19 day gestation
period. Thus, to avoid potential problems with the perdurance of
Fn1 mRNA or protein after Cre-mediated recombination, we chose
mouse lines in which Cre expression in the cardiac NC occurred
early enough to ablate Fn1 before Fn1 mRNA was synthesized.
Hence, we chose the transgenic P3Pro-Cre line and the knock-in
Tfap2aIRESCre strain for our experiments (Li et al., 2000; Macatee
et al., 2003). In these strains, Cre expression in the cardiac NC is
already evident by the 5th-somite stage, which is ∼6 h prior to the
onset of Fn1 mRNA expression in that region (Mittal et al., 2010;
Stottmann and Klingensmith, 2011). To conditionally ablate Fn1
in the NC and its derivatives, we mated Fn1flox/flox animals
harboring either the lacZ (R26R/R26R) or GFP (ROSAmTmG)
reporters in a homozygous state with Fn1+/−; P3Pro-Cre+ or
Fn1+/−; Tfap2aIRESCre/+ mice (Muzumdar et al., 2007; Soriano,
1999). The inclusion of reporters allowed the identification and
tracking of NC descendants in control and mutant embryos. The
relevant domains of Cre expression in these strains are
schematically shown in Fig. S1A-B′. The use of P3Pro-Cre and
Tfap2aIRESCre strains resulted in efficient downregulation of Fn1
mRNA (compare Fig. 1C-C″ with 1E-E″) and protein (compare
Fig. 1D,D′ with 1F,F′) from the cardiac NC. In these and all other
assays presented in this work, NC cells were identified by
expression of GFP due to the presence of the ROSAmTmG reporter
allele (Muzumdar et al., 2007). For these and all other experiments
involving immunofluorescence, the native GFP and tdTomato
fluorescence was extinguished, as described in the Materials and
Methods. Fn1 protein remaining around the pharyngeal blood
vessels in the mutants (Fig. 1F,F′) is synthesized by the
endothelium (arrows in Fig. 1E-E″).
Fig. 1. Fn1 mRNA and protein are downregulated in cardiac NC cells in Fn1flox/−; Tfap2aIRESCre/+ mutant embryos. (A) Schematic left-side view of
pharyngeal arch arteries 3, 4 and 6 connecting the heart with the dorsal aorta. Sections in all figures were cut along coronal planes (dotted line), the axes
are marked. (B) Schematic view of a coronal section through the pharyngeal region. PAAs are numbered, axes are indicated. (C-D′) Controls. (E-F′) Mutants.
(C-C″ and E-E″) Fn1mRNA. In Fn1flox/−; Cre+mutants, Fn1mRNA is downregulated in the NC but not in the PAA endothelium (arrows). Magnified views of the 4th
and 6th PAAs are shown in C′,C″ and E′,E″. Endoderm (en) is outlined by dotted lines. Arrows in C′ and E-E″ indicate endothelial cells. (D,D′,F,F′) Neural crest
(GFP+, blue), Fn1 (red), Pecam1 (green). Fn1 protein is downregulated in Fn1flox/−; Cre+ mutants. The native GFP fluorescence was extinguished by boiling
sections in 10 mM citric acid (see supplementary Materials and Methods). See also Fig. S1. Scale bars: 100 μm.
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Cardiovascular phenotypes of the Fn1flox/−; P3Pro-Cre+ and
Fn1flox/−; Tfap2aIRESCre+mutant embryos were comparable (Fig. 2,
Fig. S2A-F and Tables S1 and S2). These mutants rarely survive the
neonatal period (552 progeny were genotyped, Table S1) and
exhibit a plethora of cardiovascular defects (Table S2).We also used
the originalWnt1-Cre1 strain to complement our experiments (Jiang
et al., 2000), but we observed only one incidence of RERSA among
42 Fn1flox/−; Wnt1-Cre1 embryos. Use of the newWnt1-Cre2 strain,
which was constructed to avoid the drawbacks of the Wnt1-Cre1
strain (Lewis et al., 2013), resulted in cardiovascular defects in 4 of
8 Fn1flox/−; Wnt1-Cre2mutants (Fig. S2G-L′ and Table S2). One of
these mutants had both RERSA and IAA-B. The difference in the
incidence of AAA defects between Fn1flox/−; Wnt1-Cre1 and
Fn1flox/−; Wnt1-Cre2 mutants is significant, P=0.0001 (two-tailed
Fisher exact test). The NC is the common domain of Cre expression
among the Tfap2aIRESCre, P3Pro-Cre and Wnt1-Cre2 strains
(Fig. S1A′,B′,C′), indicating that the ablation of Fn1 in the NC
caused the observed phenotypes. Since the Wnt1-Cre2 strain
became available only recently, the majority of data in this paper
were generated using the Tfap2aIRESCre and P3Pro-Cre strains. The
phenotypes of mutants generated using these strains were similar;
Therefore for clarity, we will designate Fn1flox/−; Tfap2aIRESCre/+
and Fn1flox/−; P3Pro-Cre embryos as Fn1flox/−; Cre+ mutants and
their Cre+ littermate controls, as Fn1flox/+; Cre+, in the main text.
The most common malformations in Fn1flox/−; Cre+ mutants
were: (1) aberrant patterning of the aortic arch arteries (compare
Fig. 2A,B with D,E; see Fig. S2). The incidence of AAA defects
varied from 57% to 82% among the three strains assayed (Table S2);
(2) formation of the intracardiac cartilage, similar to that described in
Gao et al. (2010) occurred at 89-100% penetrance (Chen et al.,
2015); and (3) the membranous ventricular septal defect (VSD;
curved arrow in Fig. 2F): 29-42% penetrance (Table S2). Cardiac
NC contributes mesenchymal cells to the thymus, regulating
morphogenesis of this organ (Bockman and Kirby, 1984);
consistent with that, we found that 44% of mutant embryos had
mild defects in thymus development (Chen et al., 2015). Taken
together, these phenotypes are characteristic of many other mouse
mutants with defective development or function of the cardiac NC
(Hutson and Kirby, 2007). None of these malformations were
observed in 267 control embryos examined at E14.5, E16.5 or E18.5.
NC cells arising at the same level of the neural tube as the cardiac
NC, also contribute to the cardiac, enteric, sympathetic,
parasympathetic and sensory nervous systems (Le Douarin and
Kalcheim, 1999). However, with the exception of the palatal
shelves, all other NC-derived lineages, such as dorsal root ganglia
(n=4/4 mutants), enteric nervous system (n=14/15 mutants) and
parasympathetic innervation of the heart and the diaphragm (n=6/6
mutants) developed grossly normally in Fn1flox/−; Cre+ mutants
(Fig. S2M-T). Cleft palates were found in all Fn1flox/−;
Tfap2aIRESCre/+ mutants and in 4 out of 5 Fn1flox/−; Wnt1-Cre2
mutants (Fig. S2U-X). These findings indicate that NC-derived Fn1
is specifically required for the development of a narrow subset of the
cranial NC.
NC-derived Fn1 is required for the differentiation of NC cells
into vascular smooth muscle cells
AAA defects in Fn1flox/−; Cre+ mutants generated using the
TFAp2aIRESCre, P3Pro-Cre or Wnt1-Cre2 strains included
RERSA, interrupted aortic arch type B (IAA-B), hypoplastic aortic
arch and the right-sided aortic arch (Fig. 2, Fig. S2, Table S2); in 6
of 43 Fn1flox/−; Cre+ mutants, RERSA and IAA-B occurred
concurrently. These defects are specific to abnormal development
of the 4th pair of PAAs (Stoller and Epstein, 2005) and could be due
to either defective PAA formation or defective remodeling of the
well-formed PAAs into theAAAs (Conway et al., 2003). Injection of
black India ink into the hearts of control andmutant embryos isolated
at E10.5 showed that the three pairs of PAAs formed normally (n=3)
(Chen et al., 2015). Similarly, examination of histological sections in
n>10 mutants and controls 1 day later, at E11.5, indicated that all of
the PAAs werewell formed in the mutants (e.g. compare Fig. 3A,E).
Therefore, the AAA defects observed in our mutants at E14.5-E16.5
were due to pathological regression of the initially well-formed 4th
pair of PAAs. These phenotypes are analogous to other mutants with
defective development of the cardiac NC (Hutson and Kirby, 2007).
In such mutants the originally well-formed 4th pair of PAAs
regressed because of either (a) insufficiency in cardiac NC cell
population or (b) defective differentiation of the cardiac NC into
VSMCs (Conway et al., 2003; Stoller and Epstein, 2005).
Consistent with our previous studies showing that Fn1 was not
required for NC migration in global Fn1-null mutants (Mittal et al.,
2010), the deletion of Fn1 in NC cells did not impair NC migration
(compare Fig. S3A-B″ with C-D″). However, unlike in the global
Fn1-null embryos, Fn1 synthesized by the NC was not required for
NC cell survival (Fig. S3B‴,D‴), suggesting that other cellular
sources of Fn1 regulate NC survival.
At E11.5, population densities of NC-derived cells in the control
andmutant pharyngeal arches were comparable (compare Fig. 3A,E,
blue; quantified in Table S3). However, the coverage of the 4th pair
of PAAs with VSMCs was defective in 17 of 25 Fn1flox/−; Cre+
mutants (compare Fig. 3A-D with E-H; quantified in Fig. S4). Four
VSMC markers were assayed, αSMA (Acta2), SM22α (Tagln1),
calponin (Cnn1) and smooth muscle myosin heavy chain 11
(Myh11), and we found coordinated downregulation of all of these
markers in cardiac NC-derived cells in Fn1flox/−; Cre+ mutants
(Fig. 3E-H). As expected, the development of VSMCs around the
dorsal aorta (DA) was not affected in our mutants (Fig. 3A,E)
because these VSMCs are derived from the mesodermal progenitors
and not from the NC.
Vascular expression of the ECM protein fibulin-1, which is
required for the development of the cardiac NC and AAA
Fig. 2. Fn1flox/−; Tfap2aIRESCre/+ mutants develop defects in AAA
morphogenesis and ventricular septation. (A-C) Controls; (D-F) mutants.
Small arrow in D indicates missing aortic arch (AA) in the mutants. Arrow in E
indicates RERSA (retroesophageal right subclavian artery), originating from
the dorsal aorta (dAo). (C,F) Coronal sections through the equivalent levels of
control (C) and mutant (F) hearts show the presence of the ventricular septal
defect (VSD, curved arrow in F) in the mutants. AA, aortic arch; dAo, dorsal
aorta; lca, rca, left and right carotid arteries; lsa, rsa, left and right subclavian
arteries; PT, pulmonary trunk; a, aortic valve; m, mitral valve; LV and RV, left
and right ventricles. See also Fig. S2. Scale bars: 200 μm.
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morphogenesis (Cooley et al., 2008) was not affected in our mutants
(Fig. 3I-I″,M-M″) and neither was the expression of laminin γ-1
(Fig. 3J-J″,N-N″), which is a component of vascular basement
membranes (Yurchenco, 2011). We also did not observe differences
in activation of SMAD2/3 and SMAD1/5/8 between controls and
mutants (Fig. S6). Proliferation and survival of NC cells surrounding
the PAAs (Fig. 3K,L,O,P) were also not affected in the mutants,
Table S3. Taken together, our data indicate that Fn1 synthesized by
NC-derived cells is required for the differentiation of NC cells into
VSMCs. Furthermore, thesedata suggest that themechanisms of Fn1-
mediated NC-to-VSCM differentiation do not involve the regulation
of ECM deposition or signaling by the TGFβ family of proteins.
Remodeling of the PAAs observed in wild-type embryos
involves stage-dependent, stereotypical regression of the right 6th
PAA and partial regression of the right 4th PAA, which gives rise to
a small segment of the right subclavian artery (Hutson and Kirby,
2007); the left 4th PAA persists and gives rise to the aortic arch. The
left 6th PAA persists during fetal development and gives rise to the
ductus arteriosus (Hutson and Kirby, 2007). By contrast, in animal
models with cardiac NC deficiency, PAA regression occurs at
random (Leatherbury et al., 1990; Nishibatake et al., 1987; Olaopa
et al., 2011; Porras and Brown, 2008). This leads to variable
aberrations in the final configuration of the AAAs, similar to the
phenotypes observed in our mutants (Table S2, Fig. 2 and Fig. S2).
Consistent with these findings, we observed that NC differentiation
into VSMCs was affected on the left, right or both sides of the
mutant embryos (Fig. S4). VSMC deficiency around the left 4th
PAA is expected to result in the regression of this PAA, and give rise
to the interrupted aortic arch (IAA-B). VSMC deficiency around the
right 4th PAA is expected to result in the regression of the right 4th
PAA and to give rise to RERSA, and we observed IAA-B, RERSA
or both IAA-B and RERSA in Fn1flox/−; Cre+ mutants (Fig. 2,
Fig. S2 and Table S2). Taken together, our studies indicate that
defective morphogenesis of AAAs in Fn1flox/−; Cre+ embryos result
from the reduced differentiation of cardiac NC cells into VSMCs
and that the NC-derived source of Fn1 plays a fundamental role in
regulating cardiovascular morphogenesis.
NC-synthesized Fn1 regulates the differentiation of NC cells
into smooth muscle cells in an NC cell-autonomous manner
On their way to pharyngeal arches, NC cells migrate through the
cranial mesoderm that expresses Fn1 (Mittal et al., 2010; Peters and
Hynes, 1996). NC cells directly adjacent to the PAA endothelium
within the pharyngeal arches are exposed to endothelial Fn1
(Fig. 1C-D′,E-F′). Nevertheless, these paracrine sources of Fn1 are
not sufficient to support the differentiation of NC cells into VSMCs
and AAA morphogenesis (Fig. 2A,B,D,E, Fig. S2A-K′ and Fig. 3).
Taken together, these data suggest that NC-derived Fn1 mediates
differentiation of NC cells into VSMCs in NC cell-autonomous
manner. In order to test this hypothesis directly, we isolated NC
cells from one of two sources: from a fragment of the neural tube
(NT) located between the otic pit and the 4th somite and
corresponding with the origin of the cardiac NC (Fig. 4A,B) or
from the pharyngeal arches 3-6 containing cardiac NC cells,
including those destined to give rise to PAAVSMCs (Fig. 4C,D). In
these assays, NC cells were identified by the expression of GFP due
Fig. 3. NC-derived Fn1 is required for the differentiation of NC cells into VSMCs in vivo. Coronal sections of control (A-D,I-L) and mutant (E-H,M-P) E11.5
embryos. Analyses of VSMCmarker expression in control (A-D) and mutant (E-H) embryos show deficient expression of VSMCmarkers in NC cells (GFP+, blue)
surrounding the PAAs in the mutants. Boxed areas in A and E are expanded in A′-A‴ and E′-E‴. The expression of ECM proteins fibulin-1 and laminin γ1 are
comparable around the PAAs in controls (I-J″) and mutants (M-N″). Proliferation (K,O) and survival (L,P) of NC cells around the PAAs is not affected in the
mutants. Axes are marked. Pharyngeal arch arteries are numbered. DA, dorsal aorta; R4, right fourth PAA. Native GFP fluorescence was extinguished by boiling
sections in 10 mMcitric acid (see supplementaryMaterials andMethods). For additional NC analyses at E9.5, see Fig. S3. For quantification of VSMC coverage at
E11.5, see Fig. S4. Scale bars: 100 μm in A,E; 50 μm in all other panels.
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to the presence of the ROSAmTmG reporter allele (Muzumdar et al.,
2007). Expression of αSMA (Acta2) or calponin (Cnn1) was used as
a readout of smooth muscle differentiation. These experiments
demonstrated that Fn1-deficient NC cells were impaired in their
differentiation into smooth muscle cells in vitro (Fig. 4A-D,
quantified in Fig. 4E,F).
Fn1 protein is highly evolutionarily conserved among species
(Hynes, 2012) and isolated Fn1 proteins from different species are
used interchangeably in vitro. In all of the in vitro experiments
described above, NC cells isolated from control and mutant embryos
were cultured in the presence of 10% fetal bovine serum and
contained plasma Fn1, one of the most abundant serum proteins.
However, the presence of plasma Fn1was not sufficient to restore the
full smoothmuscle differentiation potential to Fn1-deficient NC cells
(Fig. 4E,F). It is important to note that the differentiation of control
NC cells into smooth muscle cells in the presence of Fn1-depleted
FBS was minimal in both control and mutant NC cultures (data not
shown). This latter observation is consistent with the studies
described by Costa-Silva et al. (2009), which suggested that plasma
Fn1 potentiates the differentiation of NC cells into VSMCs.
Plasma Fn1 is different from Fn1 synthesized by NC cells, since
virtually all embryonic forms of Fn1 include the EIIIA and EIIIB
alternatively spliced exons at mid-gestation, whereas plasma Fn1
is devoid of both (Astrof et al., 2007; Hynes, 1990; Peters and
Hynes, 1996). Our previous genetic studies indicated that
EIIIA−EIIIB− forms of Fn1 were insufficient to support normal
embryonic development, and that deletion of both the EIIIA and
EIIIB exons from Fn1 led to NC-related cardiovascular defects,
despite the fact that EIIIA−EIIIB− Fn1 in these mutants was
synthesized at levels similar to those of wild-type Fn1 in control
embryos (Astrof et al., 2007). In addition, soluble plasma Fn1 in
culture medium could be in a different conformation than the
solid-state Fn1 present in ECM or adsorbed to tissue culture plates.
To test whether Fn1-coated glass slides could rescue smooth
muscle differentiation in Fn1-deficient NC cells, we plated control
and mutant NC cells on glass coverslips coated with collagen 1,
human plasma Fn1 or human cellular Fn1 containing EIIIA and
EIIIB splice variants (Fig. 4G). However, consistent with our
in vivo data, Fn1 provided in trans did not rescue smooth muscle
differentiation defects in Fn1-deficient NC cells (Fig. 4G). These
findings indicate that NC-derived Fn1 regulates smooth muscle
differentiation in a NC cell-autonomous manner.
NC-synthesized Fn1 regulates Notch signaling
Several pathways are known to regulate the differentiation of NC-
derived cells into VSMCs around PAAs 3-6 (Arnold et al., 2013;
High and Epstein, 2008; Kaartinen et al., 2004; Li et al., 2005; Oh
et al., 2005; Vallejo-Illarramendi et al., 2009). Among these, the
role of Notch signaling has been particularly well studied (High and
Epstein, 2008; High et al., 2008, 2007; Manderfield et al., 2015,
2012). Active Notch is an upstream regulator of NC differentiation
into VSMCs (High et al., 2007; Manderfield et al., 2012). Prior
experiments indicated that Notch signal is transduced from PAA
endothelial cells to the adjacent NC-derived mesenchyme, leading
to the expression of Notch target genes Jagged1, Hey1 and Hey2 in
the NC. Notch signal is then relayed from one NC cell layer to the
next as a result of induction of Jagged1 in these cells – a process
termed lateral induction (Eddison et al., 2000; Manderfield et al.,
2012; Ross and Kadesch, 2004). In this process, Jagged1 expressed
by the proximal NC cells binds Notch expressed in next NC cell
layer, which activates Notch signaling. The relay of Notch signal
through the consecutive NC cell layers leads to smooth muscle gene
expression and VSMC differentiation in those NC cells that are
marked by the activated Notch (Boucher et al., 2011; Doi et al.,
Fig. 4. Fn1 synthesized by the NC regulates the differentiation of NC cells into smooth muscle cells in vitro. NC cells were cultured under smooth
muscle differentiation conditions. (A,B) Cardiac NC cells isolated from control (A) andmutant (B) neural tubes at E8.5. NC cells are GFP+ (green). Note prominent
αSMA+ stress fibers (red) in controls (A) and their absence in mutant NC cells (B). Arrows indicate NC cells. GFP− αSMA+ cells (arrowheads) are mesodermal
cells co-isolated with the NC. NC cells from control (C) and from mutant embryos (D) isolated from the pharyngeal arches 3-6 at E9.5. Arrows indicate NC
cells (green), arrowheads indicate mesodermal cells. Calponin (red) is expressed by control but not by mutant NC-derived cells. (E) Analyses of SMC
differentiation in NC cells isolated from a single embryo are plotted individually. A total of 813 NC cells were analyzed from 3 Fn1flox/−; Cre+mutant embryos and
676 NC cells were analyzed from 3 control embryos. (F) 963 NC cells from 7 Fn1flox/+; Cre+ control embryos and 892 NC cells from 5 Fn1flox/−; Cre+ mutant
embryos were analyzed. (G) NC cells isolated from the pharyngeal arches at E9.5 were cultured on coverslips coated with the indicated ECM proteins and stained
to detect αSMA. Each data point is collected from one cultured embryo. Culture of Fn1-deficient NC cells on plasma or cellular Fn1 did not rescue smooth
muscle differentiation in these cells. A total of 973 control and 1175mutant NC cells plated on collagen 1 were imaged and quantified; 780 control and 847mutant
NC cells plated on pFn1 were imaged and quantified, and 843 control and 1062 mutant NC cells plated on cFn1 were imaged and quantified. Statistics were
performed using two-tailed, unpaired Student’s t-test with Welch’s correction for unequal s.d. Means±s.d. are shown. Scale bars: 50 μm.
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2006; High et al., 2008; Manderfield et al., 2012; Noseda et al.,
2006; Tang et al., 2008). However, the Notch signal is not relayed
through the indefinite number of NC cell layers, but is confined to a
few NC cell layers nearest the PAA endothelium (High et al., 2007).
How this relay is terminated is unknown (Manderfield et al., 2012).
We noticed that the expression domains of Fn1 and Jagged1
proteins overlapped and diminished coordinately with increasing
distance from the PAAvessel lumen (Fig. 5A-E). The expression of
Fn1 mRNA is also enriched in NC layers proximal to the PAA
endothelium (Fig. 1C-C″) and this expression pattern corresponds
with the mRNA expression of other downstream targets of Notch –
Hey1 and Hey2 (Fig. 5J,K and Fig. 6I-J′). These data show that
Notch signaling around the PAA endothelium is mainly active
within the NC cell layers that express Fn1.
These observations prompted us to ask whether Fn1 regulated
Notch signaling in the NC. To answer this question, we investigated
the expression of Notch transcriptional targets Jagged1, Hey1 and
Hey2, as well as the expression of the active form of Notch – the
Fig. 5. Fn1 regulates Notch signaling in NC cells surrounding the PAAs. (A-E) The Fn1 (red) and Jagged 1 (green) proteins are co-enriched in NC cells
surrounding thePAAendothelium.Fluorescence intensityalong the line inD is plotted inE. (A-G′, J-M)Controls; (H-I′,N-Q)mutants. Jagged1 fluorescence (green)
(F,H) is shown in a separate channel (F′,H′). White arrows indicate the extent of Jagged1 expression around the PAA. (F″,H″) Jagged1 fluorescence measured
along the red lines is shown in F′ and H′ using the plot profile function in ImageJ. Each peak of fluorescence occurs at cell borders. In control (F-F″), Jagged1
fluorescence is detectable over four cell borders; in the mutant (H-H″) Jagged1 expression wanes at the third cell border. The first cell border occurs at the
endothelial–NC interface. (G,G′,I,I′) NICD in the nuclei of NC cells surrounding the right 4th PAA in control (G,G′, arrowheads). NICD expression in the mutant is
mainly confined to thePAA lumen (I′, arrows). (J-Q) In situhybridization. In controls (J-K),Hey1andHey2areexpressed in thePAAendotheliumand in adjacentNC
cells. In themutants,Hey1 andHey2 expression is confinedmostly to the endothelium (arrows) (N,O). The expression patterns ofNotch1 andNotch3 are similar in
controls (L,M) and in the mutants (P,Q). Endoderm (en) is outlined by the dotted lines. Axes are shown. Scale bars: 50 μm in J-Q; 30 μm in all other panels.
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Notch intracellular domain (NICD) – inNC cells surrounding the 4th
pair of PAAs in Fn1flox/−; Cre+ mutants and controls at E11.5. For
these analyses, we chose those Fn1flox/−; Cre+ mutants in which
αSMA expression in the NC around the PAAs was downregulated
and used their littermate controls for comparisons (Fig. 5F-Q). Our
experiments indicated that the expression of Jagged1 was
downregulated in 5 of 6 Fn1flox/−; Cre+ mutants with defective
VSMC differentiation (compare Fig. 5F,F′ with H,H′). Moreover,
compared with the mutants, expression of Jagged1 in controls was
maintained over a wider number of NC cell layers surrounding the
PAAs (compare Jagged1 intensity profiles in Fig. 5F″,H″, each peak
is Jagged1 fluorescence at consecutive cell borders). Similarly,
NICD was expressed in multiple NC cell layers surrounding the 4th
PAA in controls (Fig. 5G,G′, arrowheads). By contrast, the
expression of NICD in the NC was downregulated in all 3 of 3
examined Fn1flox/−; Cre+ mutants (Fig. 5G,G′,I,I′) and was mainly
confined to the endothelial cell layer (Fig. 5I′, arrows). Hey1 and
Hey2 mRNAs were downregulated in 4 of 4 examined Fn1flox/−;
Cre+ mutants (Fig. 5J,K,N,O).
Antibodies against the activated form of Notch (NICD) recognize
cytoplasmic domains of Notch1 and Notch3. To test whether Fn1
regulated Notch signaling through expression of Notch1 and
Notch3, we performed in situ hybridization to detect the
expression of these receptors in the mutants with downregulated
expression of αSMA and Jagged1. These experiments showed that
Notch1 and Notch3 were expressed at similar levels in controls
and Fn1flox/−; Cre+ mutants, n=3/3, (Fig. 5L,M,P,Q). These
findings suggested that Fn1 regulates Notch signaling rather than
the expression of Notch receptors.
Taken together, our studies demonstrated that NC-synthesized
Fn1 regulates Notch signaling in NC cells around the PAAs, and
showed that active Notch signal is confined to the region of NC cells
enriched in Fn1 protein. These results are consistent with the idea
that the enrichment of Fn1mRNA and protein in the NC cell layers
adjacent to the PAA endothelium imposes a spatial specificity to
Notch signaling, and limits Notch signaling and NC-to-VSMC
differentiation to this region.
Fn1 regulates activation of Notch and NC differentiation into
VSMCs by signaling through integrin α5β1
If Fn1 regulates the differentiation of NC cells into VSMCs in a
NC cell-autonomous manner, NC cells must express receptors that
Fig. 6. Integrin α5β1 regulates Notch signaling and VSMC differentiation in NC-derived cells. Coronal sections through E11.5 Itga5flox/+; Tfap2aIRESCre/+
control (A-D′,I-L) and Itga5flox/−; Tfap2aIRESCre/+ mutant embryos (E-H′,M-P). NICD (green) localizes to nuclei within multiple layers of NC cells (GFP+, blue,
arrows) in controls (A,A′) but in the mutants (E,E′), NICD is mainly confined to the endothelium, arrowheads. Arrows indicate NICD+ NC cells. (A′,E′) αSMA and
(B,F) calponin are downregulated in the mutants. (C-D′,G-H′) Expression of αSMA and Jagged1 are coordinately downregulated in the mutants (G-H′).
(C-D′) Views of the same control section. (G-H′) Views of the same mutant section. Arrows in D,D′,H′ indicate NC cells expressing Jagged1. Arrowheads in
D,D′,H,H′ indicate endothelial cells expressing Jagged1. Endoderm (en) is outlined by the dotted white lines in D,D′ and H,H′. Note that Jagged1 staining
in the mutants is mainly confined to the endothelial–NC cell border (dotted brown line). (I-J′,M-N′) Hey1 and Hey2 mRNAs are downregulated in the mutants
(M-N′). Compare area between the arrows in J′ and N′. The outlined boxes in J and N are expanded in J′,N′. (K,L,O,P) Expression of Notch1 and Notch3 in
NC-derived cells surrounding the PAAs were not affected in the mutants. K,L are serial sections to C-D′. O,P are serial sections to G-H′. Scale bars: 50 μm.
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transduce Fn1 signals regulating Notch signaling and NC-to-VSMC
differentiation. NC cells are known to express a number of Fn1
receptors, including αv-, α4- and α5-containing integrin
heterodimers (Grazioli et al., 2006; Haack and Hynes, 2001;
Testaz et al., 1999). Integrin α5β1 is thought to be a major Fn1
signal transducer during early to mid-gestation (George et al., 1997,
1993; Mittal et al., 2013, 2010; Pulina et al., 2014, 2011; Takahashi
et al., 2007; Yang et al., 1999, 1993). Therefore, we asked whether
integrin α5β1 was required for activation of Notch and
differentiation of NC-derived cells into VSMCs. Conditional
deletion of integrin α5 in the NC using the same Cre-expressing
strains as above resulted in defective differentiation of the cardiac
NC cells into VSMCs in 11 of 20 integrin α5 mutants (Itga5flox/−;
Cre+), assayed either by expression of αSMA or calponin (compare
red signal in Fig. 6A-C with E-G), quantified in Fig. S5. To test
whether Notch signaling in the NC was also dependent on integrin
α5, we examined Notch activation in Itga5flox/−; Cre+ mutants
exhibiting defective VSMC differentiation. Similar to Fn1flox/−;
Cre+ mutants, expression of NICD was limited to the immediate
vicinity of the PAA endothelium in 4 of 4 Itga5flox/−; Cre+mutants,
whereas in controls, NICD was present in multiple NC cell layers
(compare green signal in Fig. 6A,A′ with E,E′). As with Fn1flox/−;
Cre+ mutants, we found that Jagged1 expression was limited to the
immediate vicinity of the PAA endothelium in 5 of 5 integrin
Itga5flox/−; Cre+ mutants (compare Fig. 6D,D′ with H,H′).
Consistent with these findings, Hey1 and Hey2 mRNA was
downregulated in 4 of 4 Itga5flox/−; Cre+ mutants (compare
Fig. 6I-J′ with M-N′). Expression of Notch1 and Notch3 was not
affected in Itga5flox/−; Cre+ mutants with defective expression of
αSMA and Jagged1 (Fig. 6K,L,O,P). These findings indicated that
expression of integrin α5 by NC cells is required for Notch signaling
in the NC and differentiation of NC cells into VSMCs.
To test whether impaired Notch signaling was the cause of
defective smooth muscle differentiation in integrin-α5-deficient NC
cells, we asked whether activation of Notch in mutant NC cells
would restore their ability to differentiate into VSMCs. NC cells
isolated from Itga5flox/−; Cre+ mutants lack integrin α5β1 (compare
Fig. 7A-A″ with B-B″) and exhibit defective smooth muscle
differentiation, assayed by the expression of αSMA or calponin
(Fig. 7C,D, quantified in G, ‘not infected’ columns). However,
activation of Notch signaling in integrin-α5-deficient NC cells by
expression of the Notch1 intracellular domain N1ICD (Tang et al.,
2008) – but not of control proteins – restored smooth muscle
differentiation in these cells (Fig. 7E-G), indicating that integrin α5
regulates NC differentiation into VSMCs by activating Notch
signaling.
Our findings are consistent with the model that NC-synthesized
Fn1 regulates the activation of Notch and VSMC differentiation by
signaling through integrin α5β1 expressed by the cardiac NC. We
hypothesize that as the PAAs grow in diameter between E10.5 and
E11.5 stages of development, a morphogen secreted by the PAA
endothelium induces high levels of Fn1 expression in NC cells
adjacent to the PAA endothelium and that the region of Fn1
expression in the NC is determined by the diffusion/threshold
levels of this morphogen (Fig. 7H). Alternatively, Fn1
transcription in the NC could be induced by mechanical tension
arising due to the increasing hemodynamic shear stress on the
endothelium in the growing PAAs (Bordeleau et al., 2015;
Chiquet et al., 2003; Liu et al., 2000). Regardless of how Fn1 is
induced, our studies support the hypothesis that enriched
expression of Fn1 in NC cells around the 4th pair of PAAs
imposes a spatial specificity on Notch activation and VSMC
differentiation in the NC, and regulates the complex process of
PAA remodeling.
DISCUSSION
Role of Fn1 and integrin α5 in NC development and
cardiovascular morphogenesis
Our previous studies revealed that Fn1 mRNA and protein are
expressed in non-uniform, dynamic patterns during embryogenesis
(Mittal et al., 2010). The high evolutionary conservation of Fn1 and
the essential role of Fn1 in cardiovascular development suggested
that enriched expression of Fn1 in specific embryonic regions is
biologically significant. The studies described in this paper and in
our earlier publication (Chen et al., 2015) reveal requisite, cell type-
specific functions of Fn1 in embryogenesis and cardiovascular
development.
We used three different strains of mice, the P3Pro-Cre andWnt1-
Cre2 transgenic lines and the Tfap2aIRESCre knock-in mice to
determine the role of Fn1 synthesized by the NC. These experiments
demonstrated that specific expression of Fn1 in the NC is required
for the development of the palate and the cardiovascular system.
Furthermore, we showed that NC-synthesized Fn1 was specifically
required for the asymmetrical remodeling of the PAAs into the
AAAs by regulating Notch signaling and differentiation of NC-
derived cells into VSMCs.
Despite the presence of Fn1 at the interface between the PAA
endothelium andNC cells in Fn1flox/−; Cre+mutants, endothelial Fn1
was not sufficient to promote VSMC differentiation in the adjacent
NC, demonstrating the importance of NC cell-specific Fn1. Unlike in
global Fn1-null embryos, NC cell survival and proliferation were not
affected in the conditionalFn1flox/−; Cre+mutants, demonstrating that
Fn1 synthesized by other embryonic cell types is sufficient to support
NCproliferation and survival but not their differentiation intoVSMCs.
Studies by Costa-Silva et al. (2009) showed that plating wild-type
NC cells on plasma fibronectin-coated surfaces promoted the
differentiation of NC cells into smooth muscle cells. Our data
support these findings, since we observed only minimal smooth
muscle differentiation of wild-type NC cells in the absence of
plasma Fn1. However, we show that plasma Fn1 is not sufficient to
rescue smooth muscle differentiation in Fn1-null NC cells.
Together with the results of NC cell culture, our genetic studies
in vivo demonstrate the requirement for the NC cell-specific source
of Fn1 in the differentiation of NC cells into VSMCs.
Fn1 is alternatively spliced and we previously showed that the
presence of EIIIA or EIIIB alternatively spliced exons in Fn1 was
necessary for NC development and cardiovascular morphogenesis
(Astrof et al., 2007). However, both EIIIA+ and EIIIB+ forms of Fn1
are present around the PAAs (Astrof et al., 2007), and both the PAA
endothelium and the NC synthesize EIIIB+EIIIA+ Fn1 (our
unpublished data). Thus, differences in the alternative splicing are
unlikely to explain why endothelial Fn1 does not compensate for the
absence of NC-synthesized Fn1. Onewould expect that in Fn1flox/−;
Cre+mutants, the total levels of Fn1 are lower at the interface of the
PAA endothelium and the NC relative to controls; however, a
simple decrease in Fn1 levels cannot explain defects observed in
Fn1flox/−; Cre+ mutants, given that a 50% decrease in Fn1 protein
levels is sufficient to support normal embryogenesis and adult
homeostasis in Fn1+/−mice. Addition of ectopic Fn1 (purified from
either plasma or cellular sources) in vitro did not rescue NC-to-
VSMC differentiation in Fn1-deficient NC cells, supporting the
notion that it is the synthesis of Fn1 by the NC that is important for
VSMC differentiation of NC cells, rather than the overall levels of
Fn1 protein. These results suggest that cell-autonomous and
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paracrine sources of Fn1 could engage different signaling pathways
in the NC. Alternatively, differences between Fn1 proteins
synthesized by the NC and endothelium could be due to potential
variations in cell type-specific post-translational modifications of
Fn1.
If NC-synthesized Fn1 signaled in an NC cell-autonomous
manner, it would have to engage Fn1 receptors expressed by the NC
(Testaz et al., 1999). Previous studies demonstrated that integrin
α5β1 is a major Fn1 receptor in early and mid-gestation mouse
embryos (Chen et al., 2015; George et al., 1997, 1993; Mittal et al.,
2013, 2010; Pulina et al., 2014, 2011; Takahashi et al., 2007; Yang
et al., 1999, 1993). Therefore, we used conditional mutagenesis to
ablate integrin α5 in the NC. These studies showed that the
expression of integrin α5β1 byNC cells was required to facilitate the
differentiation of NC cells into VSMCs. Thus, our experiments
suggested that NC-synthesized Fn1 regulates the differentiation of
NC cells into VSMCs by engaging integrin α5β1 expressed by NC
cells in a cell-autonomous manner.
Much of what we know about the roles of Fn1 in cell biology has
been gleaned from studies with ectopically supplied purified Fn1
proteins (Bae et al., 2014; Hynes, 1990; Schwartz, 2010). However,
recent in vivo studies suggest that in addition to paracrine functions
(Yoshino et al., 2014), Fn1 could also signal in a cell-autonomous
manner (Cseh et al., 2010; Liu et al., 2010; Serres et al., 2014;
Stenzel et al., 2011). By using genetic and cell biological
approaches, the studies reported in this paper are the first to
demonstrate the requisite, cell-autonomous role of Fn1 in the
regulation of cardiovascular development. This discovery bears
Fig. 7. Activation of Notch rescues smooth muscle differentiation in integrin-α5-deficient NC cells. (A-A″) Control and (B-B″) mutant NC cells (green,
arrows) and mesodermal cells (arrowheads). Integrin α5 (red) and NC cells (GFP+, green), nuclei (DAPI, blue). (C,D) Control and integrin-α5-deficient NC cells,
stained for GFP (green) and calponin (red). Arrows indicate NC cells. GFP−mesodermal cells (arrowheads) act as internal positive controls for calponin staining.
(E) Mutant NC cultures from pharyngeal arches 3-6 infected with adenovirus encoding control NDRG1-FLAG protein (blue). Arrows indicate NC cells (GFP+,
green). Note that mesodermal cells (arrowheads) but not NC cells express calponin (red) in the mutant. The composite staining in E is split into separate channels
in E′ and E″; dashed boxes are magnified in Ea, E′a and E″a. (F) Mutant NC cells (GFP+, green) from the pharyngeal arches 3-6 infected with adenovirus
encoding N1ICD (nuclear localized, blue). Straight arrows indicate infected NC cells, curved open arrows indicate non-infected NC cells and an arrowhead
indicates a mesodermal cell. Note that N1ICD-infected mutant NC cells (straight arrows) but not the non-infected cells (curved open arrows) express calponin
(red). The composite staining in F is split into separate channels in F′ and F″, the dashed boxes are magnified in Fa, F′a and F″a. (G) Control or mutant NC cells
were left non-infected or were infected with either control viruses or viruses expressing N1ICD. SMC differentiation was assayed by the detection of either αSMA
or calponin. Statistics were performed using two-tailed, unpaired Student’s t-test: ***P<0.0053; NS, not significant. Each data point is collected by analyzing
NC cells isolated from one embryo. Mean and s.d. are plotted. For these experiments, we analyzed 798 non-infected controls NC cells isolated from 5 embryos,
575 control NC cells isolated from 4 embryos and infected with control virus, and 486 control NC cells isolated from 4 embryos and infected with N1ICD virus;
1201 non-infectedmutant NC cells from 6 embryos, 716mutant NC cells isolated from 5 embryos and infected with control virus, and 520mutant NC cells isolated
from 5 embryos infected with N1ICD virus. (H) Model. We hypothesize that as the PAA endothelial lumen increases between E10.5 and E11.5 stages of
development, endothelium is induced to secrete a diffusible factor regulating Fn1 expression in the NC-derived cells surrounding PAAs. This morphogen
could also be in the form of mechanical force transduced from the endothelium to the NC due to the increased blood flow through the expanding PAA. *Morphogen
could be a protein or mechanical force. Scale bars: 20 μm in A-B″; 50 μm in C,D; 40 μm in E,F.
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significant implications for the fields of regenerative biology and
tissue engineering by demonstrating that cell-specific synthesis of
ECM can modulate distinct aspects of organ morphogenesis and
that simply providing ECM in trans as an adhesive support may not
elicit the appropriate cell signaling responses.
Early and late roles of Fn1-binding integrins in AAA
morphogenesis
In our studies, we used mouse strains, in which the Cre recombinase
is expressed early in the NC development (∼5 somite stage) (Lewis
et al., 2013; Olaopa et al., 2011; Stottmann et al., 2004); this is
before the delamination of cardiac NC cells and prior to their arrival
into the pharyngeal arches. Thus, our studies specifically address the
role of Fn1 and integrin α5 in the differentiation of multi-potent NC
cells into VSMCs. By contrast, Turner et al. (2015) used the SM22α-
Cre transgenic line to ablate integrins α5 and αv in smooth muscle
lineages, including those derived from the NC. SM22α is a marker
of early smooth muscle differentiation. Thus, the downregulation of
integrins α5 and αv in Itga5/ItgavSM22-Cre double mutants has most
likely occurred after the onset of VSMC differentiation in the NC,
explaining the lack of VSMC differentiation defect in these mutants
(Turner et al., 2015). Similarly, Turlo et al. (2012) used the SM22α-
Cre transgenic line to ablate integrin β1 and showed that the
expression of β1-containing integrin heterodimers, which include
α5β1, in smooth muscle cells was important for maintaining AAA
VSMCs and AAA integrity. Taken together with the studies by
Turlo et al. (2012) and Turner et al. (2015), our work demonstrates
that signaling by Fn1 and integrin α5β1 is essential for both the
morphogenesis and maintenance of the AAAs: our studies establish
the requisite role of Fn1 and integrin α5β1 in the differentiation of
NC cells into VSMCs, thereby regulating the remodeling of
symmetrical PAAs into the AAAs. The work of Turlo et al. (2012)
and Turner et al. (2015) demonstrated that following the
differentiation of NC cells into VSMCs, signaling by α5-, αv-
and β1-containing integrin heterodimers is essential for maintaining
VSMCs and the architecture of the AAA vessel wall.
The role of Fn1 and integrin α5 in VSMC development
depends on the ontogeny of VSMC progenitors
VSMCs in diverse vascular beds arise from different progenitors.
Known embryonic sources of VSMCs include the lateral and
paraxial mesoderm, mesothelia and the NC (Jiang et al., 2000; Le
Lievre and Le Douarin, 1975; Que et al., 2008; Rinkevich et al.,
2012; Wasteson et al., 2008; Wilm et al., 2005). Studies by others
and our lab indicated that integrin α5 is not required for the
differentiation of mesodermal cells into VSMCs (Liang et al., 2014;
Turner et al., 2014, 2015). Furthermore, addition of Fn1 to
mesodermal VSMC precursors stimulated their proliferation and
the synthetic phenotype and opposed their differentiation into
smooth muscle cells (Bae et al., 2014; Hedin et al., 1988; Shi et al.,
2014). This contrasts with the roles of Fn1 and integrin α5 in
the differentiation of NC cells. Currently, it is not clear why
signaling by Fn1 and integrin α5 differs between mesoderm- and
NC-derived VSMC progenitors. However, it is widely known that
VSMCs from different tissue sources can be distinguished on the
basis of their gene expression profiles, the mechanisms regulating
their differentiation and in their susceptibility to disease and
injury (Cheung et al., 2012; Gittenberger-de Groot et al., 1999;
Majesky, 2007; Michel et al., 2012; Pfaltzgraff et al., 2014; Ruddy
et al., 2008). Furthermore, differences in genetic regulation of
VSMC development between the mesoderm and NC contribute to
pathological manifestations of congenital disorders such as Marfan
and Loeys–Dietz syndromes, both of which involve aneurisms that
develop at the borders of mesoderm- and NC-derived VSMCs
(Majesky et al., 2011; Ruddy et al., 2008). In the future, it will be
instrumental to determine the mechanisms underlying distinct
functions of Fn1 and integrin α5 in the differentiation of VSMCs
from mesodermal and NC progenitors.
Fn1 and integrin α5β1 regulate the differentiation of NC cells
into VSMCs by activating Notch signaling
Activation of Notch signaling in NC cells surrounding the PAAs is
essential for the differentiation of NC cells into VSCMs (High
et al., 2008, 2007; Manderfield et al., 2012). In this paper, we show
that Notch activation is limited to the field of NC cells expressing
Fn1 and that Fn1 facilitates activation of Notch by signaling
through integrin α5β1. How interactions between Fn1 and integrin
α5β1 regulate Notch signaling is not yet clear. However, it is
known that signaling by integrins can regulate Notch activation
both directly and indirectly. In Drosophila, integrin heterodimers
containing β1 regulate Notch activation by regulating its
intracellular trafficking or processing (Gomez-Lamarca et al.,
2014). Studies in Drosophila also showed that the activation of
Notch occurs at the tips of basal filopodia and requires the
activation of ezrin, Rac, Scar and actin polymerization (Cohen
et al., 2010; De Joussineau et al., 2003). Signaling by Fn1 and α5β1
is well known to activate Rac, the Wave/Scar complex and actin
polymerization (reviewed by Huttenlocher and Horwitz, 2011).
Thus, ablation of Fn1 or integrin α5 in the NC could interfere with
Notch signaling by interfering with actin polymerization,
formation of basal filopodia, or by altering the trafficking/
processing of Notch. An indirect role of β1-containing integrin
heterodimers in the activation of Notch was demonstrated in the
chick (Rallis et al., 2010). These studies showed that β1 integrins
activate Jagged1 transcription through ILK-mediated stabilization
of β-catenin. Stabilized β-catenin directly binds and activates
Jagged1 promoters upon translocation into the nucleus (Estrach
et al., 2006; Rallis et al., 2010). This is consistent with our
observations that Notch signaling is active in cells that express Fn1,
and that Notch signaling declines concomitant with the decrease in
Fn1 levels.
Taken together, our studies highlight the requisite role of the NC-
specific source of Fn1 during morphogenesis of the aortic arch
arteries and raise many interesting questions: do NC- and
endothelial-derived forms of Fn1 differ from each other? Do
paracrine and autocrine sources of Fn1 engage different cellular
signaling pathways? What are the mechanisms regulating Fn1
expression in the NC and what are the intracellular pathways by
which Fn1 and integrin α5β1 regulate Notch signaling?
MATERIALS AND METHODS
Mouse strains and genotyping
Details of mouse strains used can be found in supplementary Materials and
Methods. Genotyping was performed using PCR primers as described
previously (Mittal et al., 2010; Sakai et al., 2001; van der Flier et al., 2010).
All embryos up to E10.5 were staged by counting somites, older embryos
were staged by the day of vaginal plug. All animal studies were approved by
the Thomas Jefferson University Institutional Animal Care and Use
Committee.
Histology
Histology, immunohistochemistry and β-gal staining were performed as
described previously (Chen et al., 2015; Liang et al., 2014). For more details
about the procedures and antibodies, see supplementary Materials and
Methods.
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In situ hybridization was carried out using Fn1 (316951), Hey1 (319021),
Hey2 (404651), Notch1 (404641) and Notch3 (425171) RNA probes
synthesized by Advanced Cell Diagnostics (ACD). Detection was done
using RNAscope 2.0 FFPE Assay Brown kit according to the
manufacturer’s protocol (ACD). After the signal was developed, sections
were counterstained with Gill’s hematoxylin.
Quantification of vessel coverage by VSMCs
VSMC coverage (Figs S4 and S5) was determined using coronal sections
from control and mutant embryos dissected at E11.5. Quantification of 4-18
sections per pharyngeal arch per embryo was performed using ImageJ
software. Equivalent numbers of sections were analyzed for each set
composed of one control and one mutant embryo and 5-6 sets of control and
mutant embryos were analyzed per experiment. To determine VSMC
coverage, we calculated the fraction of vessel perimeter occupied by αSMA+
or SM22α+ signal.
Neural tube explant culture and immunofluorescent staining of
NC cells
Control and mutant embryos were obtained by crossing Fn1+/−;
Tfap2IRESCre females with Fn1flox/flox;ROSAmT/mG male mice. E8.5
embryos (15 somites) were dissected in PBS. To obtain integrin-α5-
deficient NC cells and their controls, we crossed Itga5+/−; Tfap2aIRESCre or
Itga5+/−; P3Pro-Cre females with Itga5flox/flox; ROSAmT/mGmale mice. The
neural tube (NT) from the otic placode to the fourth somite was dissected out
and incubated in collagenase/dispase (100 μg/ml; Roche, 11097113001) for
7 min at room temperature. The neural tube was microdissected from the
surrounding mesenchyme and the surface ectoderm, and then longitudinally
plated on 12 mm glass coverslips pre-coated with 100 μg/ml collagen type I
(BD Biosciences, 354249) in 4-well plates (Thermo Scientific, 12-566-
350). To induce smooth muscle differentiation, explants were cultured for 3
days at 37°C and 5% CO2 in high glucose DMEM (Invitrogen) containing
10% fetal bovine serum (BenchMark FBS, Gemini Bio-Products).
To culture NC cells from the pharyngeal arches 3-6 isolated from E9.5
mouse embryos, embryos were incubated with 150 μg/ml collagenase/
dispase for 3 min. Surface ectodermwas peeled off and pharyngeal arches 3-
6 were dissected out, plated as above, then cultured in NC self-renewal
medium for 4 days (Bixby et al., 2002). On the 5th day, NC cultures were
digested using 0.25% trypsin into single cells and plated on 12 mm glass
coverslips pre-coated with either 150 μg/ml collagen I, 10 μg/ml plasma Fn1
(BD Biosciences, 356008) or 10 μg/ml cellular Fn1 (Sigma, F2518). We
confirmed that cellular Fn1 but not plasma Fn1 contained the EIIIA domain
by western blotting using anti-EIIIA antibody (Sigma, F6140).
Smooth muscle differentiation conditions and quantification
To induce smooth muscle differentiation, cells were cultured in DMEM
containing 10% FBS at 37°C and 5% CO2 until all cells attached (2 h). After
this, NC cells were either left in the medium for the additional 48 h or treated
with adenoviruses (see below) for 2 days. Cells were then fixed in 4% PFA
for 20 min at room temperature, washed and blocked for 30 min with 10%
normal donkey serum in PBS/0.05% Tween-20. Cells were incubated
overnight at 4°C with primary antibodies diluted in blocking buffer. After a
thorough washing step the next day, cells were incubated for 1 h at room
temperature with secondary antibodies and mounted with ProLong Gold
antifade. Images were captured with a Zeiss Axiovert inverted fluorescence
microscope.
NC cultures were stained to identify NC-derived cells (GFP+, due to the
presence of ROSAmTmG reporter allele), smooth muscle cells (αSMA or
calponin 1) and DAPI (nuclei). For infected cultures, cells were also stained
to identify infected cells using antibodies directed against either the FLAG
or V5 tags (for further details see supplementary Materials and Methods).
All cells in each well were photographed at 20× magnification and coded
to conceal the identity of NC cell genotypes. The data were quantified
without the knowledge of genotypes. Following quantification, the identity
of the samples was decoded and results were analyzed using Prism 6
software (GraphPad). To quantify differentiation of untreated control and
integrin-α5-deficient NC cells or NC cells infected with control or N1ICD-
encoding viruses, we performed at least four independent experiments, all
plotted in Fig. 7G.
Adenoviral infection
Adenoviruses expressing V5-tagged Notch 1 intracellular domain (N1ICD)
were produced by the Viral Vector Core at the Maine Medical Center
Research Institute (Tang et al., 2008). The N1ICD virus stock concentration
was 1.3×1013 viral particles/ml. Control adenoviruses were produced using
RAPAd CMV adenoviral expression system (Cell Biolabs, San Diego, CA,
USA). Stock adenoviral concentration was 4×1011 pfu/ml. Viral stock
solutions were diluted 1:1000 in DMEM containing 10% FBS and 300 μl
was used to infect the cells. Viruses were incubated with NC cells at 37°C
and 5% CO2 for 48 h. Cells where then fixed for 20 min with 4% PFA at
room temperature, washed with PBS and stained using antibodies against
GFP, αSMA or calponin, and V5 or FLAG tags.
Statistics
Data were analyzed by two-tailed, unpaired Student’s t-tests or by two-way
ANOVA, as indicated in figure legends utilizing Prism 6 GraphPad
software. A P-value of less than 0.05 was considered significant.
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De Joussineau, C., Soulé, J., Martin, M., Anguille, C., Montcourrier, P. and
Alexandre, D. (2003). Delta-promoted filopodia mediate long-range lateral
inhibition in Drosophila. Nature 426, 555-559.
Doi, H., Iso, T., Sato, H., Yamazaki, M., Matsui, H., Tanaka, T., Manabe, I., Arai,
M., Nagai, R. and Kurabayashi, M. (2006). Jagged1-selective notch signaling
induces smooth muscle differentiation via a RBP-Jkappa-dependent pathway.
J. Biol. Chem. 281, 28555-28564.
Donoghue, P. C. J., Graham, A. and Kelsh, R. N. (2008). The origin and evolution
of the neural crest. Bioessays 30, 530-541.
Eddison, M., Le Roux, I. and Lewis, J. (2000). Notch signaling in the development
of the inner ear: lessons from Drosophila. Proc. Natl. Acad. Sci. USA 97,
11692-11699.
Estrach, S., Ambler, C. A., Lo Celso, C., Hozumi, K. and Watt, F. M. (2006).
Jagged 1 is a beta-catenin target gene required for ectopic hair follicle formation in
adult epidermis. Development 133, 4427-4438.
Ferguson, C. A. andGraham, A. (2004). Redefining the head-trunk interface for the
neural crest. Dev. Biol. 269, 70-80.
Gao, Z., Kim, G. H., Mackinnon, A. C., Flagg, A. E., Bassett, B., Earley, J. U. and
Svensson, E. C. (2010). Ets1 is required for proper migration and differentiation of
the cardiac neural crest. Development 137, 1543-1551.
George, E. L., Georges-Labouesse, E. N., Patel-King, R. S., Rayburn, H. and
Hynes, R. O. (1993). Defects in mesoderm, neural tube and vascular
development in mouse embryos lacking fibronectin. Development 119,
1079-1091.
George, E. L., Baldwin, H. S. and Hynes, R. O. (1997). Fibronectins are essential
for heart and blood vessel morphogenesis but are dispensable for initial
specification of precursor cells. Blood 90, 3073-3081.
Giancotti, F. G. and Tarone, G. (2003). Positional control of cell fate through joint
integrin/receptor protein kinase signaling. Annu. Rev. Cell Dev. Biol. 19, 173-206.
Gittenberger-de Groot, A. C., DeRuiter, M. C., Bergwerff, M. and Poelmann,
R. E. (1999). Smooth muscle cell origin and its relation to heterogeneity in
development and disease. Arterioscler. Thromb. Vasc. Biol. 19, 1589-1594.
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden,
W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S. et al. (2013). Heart disease
and stroke statistics–2013 update: a report from the American Heart Association.
Circulation 127, e6-e245.
Gomez-Lamarca, M. J., Cobreros-Reguera, L., Ibanez-Jimenez, B., Palacios,
I. M. and Martin-Bermudo, M. D. (2014). Integrins regulate epithelial cell
differentiation by modulating Notch activity. J. Cell Sci. 127, 4667-4678.
Grazioli, A., Alves, C. S., Konstantopoulos, K. and Yang, J. T. (2006). Defective
blood vessel development and pericyte/pvSMC distribution in alpha 4 integrin-
deficient mouse embryos. Dev. Biol. 293, 165-177.
Haack, H. and Hynes, R. O. (2001). Integrin receptors are required for cell survival
and proliferation during development of the peripheral glial lineage.Dev. Biol. 233,
38-55.
Hedin, U., Bottger, B. A., Forsberg, E., Johansson, S. and Thyberg, J. (1988).
Diverse effects of fibronectin and laminin on phenotypic properties of cultured
arterial smooth muscle cells. J. Cell Biol. 107, 307-319.
High, F. A. and Epstein, J. A. (2008). The multifaceted role of Notch in cardiac
development and disease. Nat. Rev. Genet. 9, 49-61.
High, F. A., Zhang, M., Proweller, A., Tu, L., Parmacek, M. S., Pear, W. S. and
Epstein, J. A. (2007). An essential role for Notch in neural crest during
cardiovascular development and smooth muscle differentiation. J. Clin. Invest.
117, 353-363.
High, F. A., Lu, M. M., Pear, W. S., Loomes, K. M., Kaestner, K. H. and Epstein,
J. A. (2008). Endothelial expression of the Notch ligand Jagged1 is required for
vascular smooth muscle development. Proc. Natl. Acad. Sci. USA 105,
1955-1959.
Hutson, M. R. and Kirby, M. L. (2007). Model systems for the study of heart
development and disease: cardiac neural crest and conotruncal malformations.
Semin. Cell Dev. Biol. 18, 101-110.
Huttenlocher, A. and Horwitz, A. R. (2011). Integrins in cell migration. Cold Spring
Harb. Perspect. Biol. 3, a005074.
Hynes, R. O. (1990). Fibronectins. New York: Springer-Verlag.
Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines.Cell 110,
673-687.
Hynes, R. O. (2012). Evolution: the evolution of metazoan extracellular matrix.
J. Cell Biol. 196, 671-679.
Itasaki, N., Sharpe, J., Morrison, A. and Krumlauf, R. (1996). Reprogramming
Hox expression in the vertebrate hindbrain: influence of paraxial mesoderm and
rhombomere transposition. Neuron 16, 487-500.
Jiang, X., Rowitch, D. H., Soriano, P., McMahon, A. P. and Sucov, H. M. (2000).
Fate of the mammalian cardiac neural crest. Development 127, 1607-1616.
Kaartinen, V., Dudas, M., Nagy, A., Sridurongrit, S., Lu, M. M. and Epstein, J. A.
(2004). Cardiac outflow tract defects in mice lacking ALK2 in neural crest cells.
Development 131, 3481-3490.
Le Douarin, N. M. and Kalcheim, C. (1999). The Neural Crest, 445 pp. Cambridge:
Cambridge University Press.
Le Lievre, C. S. and Le Douarin, N. M. (1975). Mesenchymal derivatives of the
neural crest: analysis of chimaeric quail and chick embryos. J. Embryol. Exp.
Morphol. 34, 125-154.
Leatherbury, L., Gauldin, H. E., Waldo, K. and Kirby, M. L. (1990).
Microcinephotography of the developing heart in neural crest-ablated chick
embryos. Circulation 81, 1047-1057.
Lewis, A. E., Vasudevan, H. N., O’Neill, A. K., Soriano, P. and Bush, J. O. (2013).
The widely used Wnt1-Cre transgene causes developmental phenotypes by
ectopic activation of Wnt signaling. Dev. Biol. 379, 229-234.
Li, J., Chen, F. and Epstein, J. A. (2000). Neural crest expression of Cre
recombinase directed by the proximal Pax3 promoter in transgenic mice.Genesis
26, 162-164.
Li, J., Zhu, X., Chen, M., Cheng, L., Zhou, D., Lu, M. M., Du, K., Epstein, J. A. and
Parmacek, M. S. (2005). Myocardin-related transcription factor B is required in
cardiac neural crest for smooth muscle differentiation and cardiovascular
development. Proc. Natl. Acad. Sci. USA 102, 8916-8921.
Liang, D., Wang, X., Mittal, A., Dhiman, S., Hou, S.-Y., Degenhardt, K. and
Astrof, S. (2014). Mesodermal expression of integrin alpha5beta1 regulates
neural crest development and cardiovascular morphogenesis. Dev. Biol. 395,
232-244.
Liu, C., Yao, J., Mercola, D. and Adamson, E. (2000). The transcription factor
EGR-1 directly transactivates the fibronectin gene and enhances attachment of
human glioblastoma cell line U251. J. Biol. Chem. 275, 20315-20323.
Liu, K., Cheng, L., Flesken-Nikitin, A., Huang, L., Nikitin, A. Y. and Pauli, B. U.
(2010). Conditional knockout of fibronectin abrogates mouse mammary gland
lobuloalveolar differentiation. Dev. Biol. 346, 11-24.
Macatee, T. L., Hammond, B. P., Arenkiel, B. R., Francis, L., Frank, D. U. and
Moon, A. M. (2003). Ablation of specific expression domains reveals discrete
99











functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and
pharyngeal development. Development 130, 6361-6374.
Majesky, M. W. (2007). Developmental basis of vascular smooth muscle diversity.
Arterioscler. Thromb. Vasc. Biol. 27, 1248-1258.
Majesky, M. W., Dong, X. R. and Hoglund, V. J. (2011). Parsing aortic aneurysms:
more surprises. Circ. Res. 108, 528-530.
Manderfield, L. J., High, F. A., Engleka, K. A., Liu, F., Li, L., Rentschler, S. and
Epstein, J. A. (2012). Notch activation of Jagged1 contributes to the assembly of
the arterial wall. Circulation 125, 314-323.
Manderfield, L. J., Aghajanian, H., Engleka, K. A., Lim, L. Y., Lui, F., Jain, R., Li,
L., Olson, E. N. and Epstein, J. A. (2015). Hippo signaling is required for Notch-
dependent smooth muscle differentiation of neural crest. Development 142,
2962-2971.
Michel, J.-B., Li, Z. and Lacolley, P. (2012). Smooth muscle cells and vascular
diseases. Cardiovasc. Res. 95, 135-137.
Mittal, A., Pulina, M., Hou, S.-Y. and Astrof, S. (2010). Fibronectin and integrin
alpha 5 play essential roles in the development of the cardiac neural crest. Mech.
Dev. 127, 472-484.
Mittal, A., Pulina, M., Hou, S.-Y. and Astrof, S. (2013). Fibronectin and integrin
alpha 5 play requisite roles in cardiac morphogenesis. Dev. Biol. 381, 73-82.
Moon, A. M. (2006). Mouse models for investigating the developmental basis of
human birth defects. Pediatr. Res. 59, 749-755.
Moon, A. (2008). Mouse models of congenital cardiovascular disease. Curr. Top.
Dev. Biol. 84, 171-248.
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. and Luo, L. (2007). A global
double-fluorescent Cre reporter mouse. Genesis 45, 593-605.
Nishibatake, M., Kirby, M. L. and Van Mierop, L. H. (1987). Pathogenesis of
persistent truncus arteriosus and dextroposed aorta in the chick embryo after
neural crest ablation. Circulation 75, 255-264.
Noseda, M., Fu, Y., Niessen, K., Wong, F., Chang, L., McLean, G. and Karsan, A.
(2006). Smooth Muscle alpha-actin is a direct target of Notch/CSL. Circ. Res. 98,
1468-1470.
Oh, J., Richardson, J. A. and Olson, E. N. (2005). Requirement of myocardin-
related transcription factor-B for remodeling of branchial arch arteries and smooth
muscle differentiation. Proc. Natl. Acad. Sci. USA 102, 15122-15127.
Olaopa, M., Zhou, H.-M., Snider, P., Wang, J., Schwartz, R. J., Moon, A. M. and
Conway, S. J. (2011). Pax3 is essential for normal cardiac neural crest
morphogenesis but is not required during migration nor outflow tract septation.
Dev. Biol. 356, 308-322.
Peters, J. H. and Hynes, R. O. (1996). Fibronectin isoform distribution in the mouse
I. The alternatively spliced EIIIB, EIIIA, and V segments show widespread
codistribution in the developingmouse embryo.Cell Adhes. Commun. 4, 103-125.
Pfaltzgraff, E. R., Shelton, E. L., Galindo, C. L., Nelms, B. L., Hooper, C. W.,
Poole, S. D., Labosky, P. A., Bader, D. M. and Reese, J. (2014). Embryonic
domains of the aorta derived from diverse origins exhibit distinct properties that
converge into a common phenotype in the adult. J. Mol. Cell. Cardiol. 69, 88-96.
Porras, D. and Brown, C. B. (2008). Temporal-spatial ablation of neural crest in the
mouse results in cardiovascular defects. Dev. Dyn. 237, 153-162.
Pulina, M. V., Hou, S.-Y., Mittal, A., Julich, D., Whittaker, C. A., Holley, S. A.,
Hynes, R. O. and Astrof, S. (2011). Essential roles of fibronectin in the
development of the left-right embryonic body plan. Dev. Biol. 354, 208-220.
Pulina, M., Liang, D. and Astrof, S. (2014). Shape and position of the node and
notochord along the bilateral plane of symmetry are regulated by cell-extracellular
matrix interactions. Biol. Open 3, 583-590.
Que, J., Wilm, B., Hasegawa, H., Wang, F., Bader, D. and Hogan, B. L. M. (2008).
Mesothelium contributes to vascular smooth muscle and mesenchyme during
lung development. Proc. Natl. Acad. Sci. USA 105, 16626-16630.
Rallis, C., Pinchin, S. M. and Ish-Horowicz, D. (2010). Cell-autonomous integrin
control of Wnt and Notch signalling during somitogenesis. Development 137,
3591-3601.
Rinkevich, Y., Mori, T., Sahoo, D., Xu, P.-X., Bermingham, J. R., Jr and
Weissman, I. L. (2012). Identification and prospective isolation of a mesothelial
precursor lineage giving rise to smooth muscle cells and fibroblasts for
mammalian internal organs, and their vasculature. Nat. Cell Biol. 14, 1251-1260.
Ross, D. A. and Kadesch, T. (2004). Consequences of Notch-mediated induction
of Jagged1. Exp. Cell Res. 296, 173-182.
Ruddy, J. M., Jones, J. A., Spinale, F. G. and Ikonomidis, J. S. (2008). Regional
heterogeneity within the aorta: relevance to aneurysm disease. J. Thorac.
Cardiovasc. Surg. 136, 1123-1130.
Sakai, T., Johnson, K. J., Murozono, M., Sakai, K., Magnuson, M. A., Wieloch,
T., Cronberg, T., Isshiki, A., Erickson, H. P. and Fässler, R. (2001). Plasma
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